Skip to content
10-Q

Quarterly Report

Petros Pharmaceuticals, Inc. PTPI

0001104659-25-111338

← back to feed
Filed
Nov 13, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 12, 2025 42.37M sh
Shares Diluted Q3 2025 · Sep 30, 2025 42.28M sh
Shares Diluted Q3 2025 · Sep 30, 2025 23.27M sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 393.19K sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 293.28K sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$5.8M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$3.57M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $6.07M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $1.72M
Stockholders Equity Q3 2025 · Sep 30, 2025 $3.37M
Stockholders Equity Q3 2025 · Jun 30, 2025 $4.45M
Stockholders Equity Q3 2025 · Dec 31, 2024 −$7.47M
Stockholders Equity Q3 2025 · Sep 30, 2024 $3.12M
Stockholders Equity Q3 2025 · Jun 30, 2024 $8.07M
Stockholders Equity Q3 2025 · Dec 31, 2023 $12.07M
Current Liabilities Q3 2025 · Sep 30, 2025 $2.77M
Current Liabilities Q3 2025 · Dec 31, 2024 $18.03M
Total Liabilities Q3 2025 · Sep 30, 2025 $2.77M
Total Liabilities Q3 2025 · Dec 31, 2024 $18.1M
Current Assets Q3 2025 · Sep 30, 2025 $6.13M
Current Assets Q3 2025 · Dec 31, 2024 $7.29M
Total Assets Q3 2025 · Sep 30, 2025 $6.13M
Total Assets Q3 2025 · Dec 31, 2024 $10.64M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.03
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.95
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$16.65
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$71.27
Eps Basic Q3 2025 · Sep 30, 2025 −$0.03
Eps Basic Q3 2025 · Sep 30, 2025 −$1.95
Eps Basic restated Q3 2025 · Sep 30, 2024 −$16.65
Eps Basic restated Q3 2025 · Sep 30, 2024 −$71.27
Sga Expense Q3 2025 · Sep 30, 2025 $990.74K
Sga Expense Q3 2025 · Sep 30, 2025 $4.25M
Sga Expense restated Q3 2025 · Sep 30, 2024 $1.2M
Sga Expense restated Q3 2025 · Sep 30, 2024 $4.05M
Net Income Q3 2025 · Sep 30, 2025 −$922.72K
Net Income Q3 2025 · Sep 30, 2025 $2.25M
Net Income Q3 2025 · Sep 30, 2024 −$2.22M
Net Income Q3 2025 · Sep 30, 2024 −$5.05M
Operating Income Q3 2025 · Sep 30, 2025 −$990.74K
Operating Income Q3 2025 · Sep 30, 2025 −$4.25M
Operating Income restated Q3 2025 · Sep 30, 2024 −$1.2M
Operating Income restated Q3 2025 · Sep 30, 2024 −$4.05M
Capex Q3 2025 · Sep 30, 2024 $19.14K